Social Media Ideas for Fesarius Therapeutics

Vera Therapeutics

Vera Therapeutics Anonymous (not verified) Sat, 09/05/2026 - 12:48 field_thread_url https://cafepharma.com/boards/threads/vera-therapeutics.713115/...

<![CDATA[METiS Enters Collaboration with Eli Lilly for Next-Generation Tissue-Specific LNP Delivery Technologies]]&gt...

Pharmacosmos Therapeutics

Pharmacosmos Therapeutics Anonymous (not verified) Fri, 10/16/2026 - 10:12 field_thread_url https://cafepharma.com/boards/threads/pharmacosmos-therapeutics...

<![CDATA[Pharmaceutical Executive Daily: Haisco Licenses Preclinical Immunology Asset to Sentivera]]>

Revolution Medicines

Revolution Medicines Anonymous (not verified) Wed, 09/30/2026 - 01:04 field_thread_url https://cafepharma.com/boards/threads/revolution-medicines.709803/...

<![CDATA[Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifyin...

Fesarius to Present Clinical Data on FDA-Cleared Dermal Regeneration Technology

The company will highlight research and surgeon experience with its dual-density collagen hydrogel technology at Plastic Surgery The Meeting 2026.

FDA extends review of Capricor cell therapy; Pain drug startup to go public

The agency is now reviewing an updated application for deramiocel with a “refined” indication. Elsewhere, a startup co-founded by Vivek Ramaswamy is taking a speedy path to the pub...

<![CDATA[Aptar and Aceso Therapeutics Enter Collaboration for Cystic Fibrosis Therapy ]]>

<![CDATA[Caribou Biosciences Discontinues Development for Vispa-cel & CB-011 CAR-T Cell Therapy Programs ]]>

<![CDATA[Roundup: Rona Therapeutics Enters Global License Agreement for ALK7-targeting RNAi Therapy, Enodia Therapeut...

Belgian startup revives Galapagos CAR-T research

Armed Cell Therapeutics, chaired by former Galapagos CEO Paul Stoffels, has assumed control of cell therapies the company — now known as Lakefront Biotherapeutics — divested in a s...

<![CDATA[FDA Approves Fayuvi for Pediatric Patients with Sanfilippo Syndrome Type A]]>

<![CDATA[Roundup: Sling Therapeutics Closes $123 Million Series C Financing, Circle Pharma Announces $92.5 Million Se...

A Takeda spinout builds case for its Parkinson’s drug

Cerevance plans to meet with the FDA to “determine next steps” for a new kind of medicine known as solengepras, now that it has Phase 3 data in hand.

Pharvaris: 'Strong Buy' Based On Deucrictibant PDUFA And Prophylaxis Trial Win

FDA approves Atebrioz for fibrodysplasia ossificans progressiva

Editor’s note: This is a developing story. Please check back soon for updates.The FDA approved zilurgisertib tablets for the reduction of heterotopic ossification among patients ag...

<![CDATA[Vir Biotechnology Enters R&D Collaboration with Gilead for Three Novel PRO-XTEN Dual Masked T-Cell Engag...

Kura spins diabetes work into a Lilly-backed biotech startup

Caspian Therapeutics aims to develop menin inhibitors, which have proven effective against leukemia, for diabetes and other cardiometabolic conditions.

Pelacarsen

Pelacarsen Anonymous (not verified) Sun, 09/13/2026 - 18:52 field_thread_url https://cafepharma.com/boards/threads/pelacarsen.718555/ bo...

<![CDATA[Foghorn Therapeutics & Eli Lilly Halt Fhd-909 Development Following Phase I Data]]>

MINERALYS THERAPEUTICS

MINERALYS THERAPEUTICS Anonymous (not verified) Mon, 09/21/2026 - 21:56 field_thread_url https://cafepharma.com/boards/threads/mineralys-therapeutics.71823...

<![CDATA[Pharmaceutical Executive Daily: Foghorn Therapeutics & Eli Lilly Discontinue Development of FHD-909]]&gt...

<![CDATA[Roundup: TRexBio & Retension Pharmaceuticals Announce IPO Pricing ]]>